These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin. Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI Cancer; 1983 Feb; 51(4):681-5. PubMed ID: 6571800 [TBL] [Abstract][Full Text] [Related]
7. [Heparin as treatment for hypercoagulability syndrome in a case of acute promyelocytic leukemia]. Pizzuto J; Gonzalez Llaven J; Uribe Cortes JA Sangre (Barc); 1969; 14(3):363-70. PubMed ID: 5288844 [No Abstract] [Full Text] [Related]
8. [The treatment of disseminated intravascular coagulation in 18 cases of promyelocytic acute leukaemia (author's transl)]. Dreyfus B; Varet B; Heilmann-Gouault M; Sultan C; Reyes F; Gluckman E; Basch A; Beaujean F Nouv Rev Fr Hematol; 1973; 13(6):761-70. PubMed ID: 4280042 [No Abstract] [Full Text] [Related]
9. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)]. Takahashi K Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410 [No Abstract] [Full Text] [Related]
10. Tissue factor activity in leukemia cells. Special reference to disseminated intravascular coagulation. Andoh K; Kubota T; Takada M; Tanaka H; Kobayashi N; Maekawa T Cancer; 1987 Feb; 59(4):748-54. PubMed ID: 3802033 [TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of heparin in the management of patients with APL. Hoyle CF; Swirsky DM; Freedman L; Hayhoe FG Br J Haematol; 1988 Mar; 68(3):283-9. PubMed ID: 3162683 [TBL] [Abstract][Full Text] [Related]
12. Case report: low-dose intravenous heparin in the treatment of disseminated intravascular coagulation. Gurewich V; Lipinski B Am J Med Sci; 1977; 274(1):83-6. PubMed ID: 911396 [TBL] [Abstract][Full Text] [Related]
13. Is heparin administration necessary during induction chemotherapy for patients with acute promyelocytic leukemia? Goldberg MA; Ginsburg D; Mayer RJ; Stone RM; Maguire M; Rosenthal DS; Antin JH Blood; 1987 Jan; 69(1):187-91. PubMed ID: 3466655 [TBL] [Abstract][Full Text] [Related]
14. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin. Sandler RM; Liebman HA; Patch MJ; Teitelbaum A; Levine AM; Feinstein DI Cancer; 1982 Nov; 50(10):2106-10. PubMed ID: 6957257 [TBL] [Abstract][Full Text] [Related]
15. Disseminated intravascular coagulation in acute leukaemias at first diagnosis. Nur S; Anwar M; Saleem M; Ahmad PA Eur J Haematol; 1995 Aug; 55(2):78-82. PubMed ID: 7628593 [TBL] [Abstract][Full Text] [Related]
16. [A case of acute myelomonocytic leukemia complicating with disseminated intravascular coagulation (DIC)]. Natori H; Yamaguchi T; Yasuda K; Egami K; Tanaka K; Kaji M; Sasaguri Y Rinsho Ketsueki; 1982 Dec; 23(12):1912-7. PubMed ID: 6962919 [No Abstract] [Full Text] [Related]
17. Fibrinolysis in patients with acute promyelocytic leukemia and disseminated intravascular coagulation during heparin therapy. Imaoka S; Ueda T; Shibata H; Masaoka T; Ogawa M; Sasaki Y; Iwanaga T; Terasawa T Cancer; 1986 Oct; 58(8):1736-8. PubMed ID: 2428461 [TBL] [Abstract][Full Text] [Related]